Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
tPA-PAI complex assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tissue plasminogen activator assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tissue plasminogen activator activity assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tissue plasminogen activator antigen assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tissue plasminogen activator antigen |
Direct substance |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
tPA-PAI complex assay |
Component |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tissue plasminogen activator assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tissue plasminogen activator activity assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tissue plasminogen activator antigen assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Reteplase (substance) |
Is a |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alteplase (substance) |
Is a |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tenecteplase (substance) |
Is a |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tissue plasminogen activator (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing reteplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alteplase 50mg injection (pdr for recon)+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alteplase 20mg injection (pdr for recon)+diluent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alteplase 10 mg, fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Reteplase 10units injection (pdr for recon)+diluent pack (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tenecteplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alteplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tenecteplase 8000iu(40mg) injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tenecteplase 10,000iu(50mg) inj (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alteplase 1mg injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Reteplase, recombinant 10unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alteplase 100mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tissue plasminogen activator only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fibrinolytic disorder caused by tissue plasminogen activator |
Causative agent (attribute) |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intravenous injection of tissue plasminogen activator |
Direct substance |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intra-arterial injection of tissue plasminogen activator |
Direct substance |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by tissue plasminogen activator (disorder) |
Causative agent (attribute) |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
tPA-PAI complex assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |